Cargando…
Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma
Ratiometric delivery of combination chemotherapy can achieve therapeutic efficacy based on synergistic interactions between drugs. It is critical to design such combinations with drugs that complement each other and reduce cancer growth through multiple mechanisms. Using hyaluronic acid (HA) as a ca...
Autores principales: | Krishnan, Vinu, Dharamdasani, Vimisha, Bakre, Shirin, Dhole, Ved, Wu, Debra, Budnik, Bogdan, Mitragotri, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874923/ https://www.ncbi.nlm.nih.gov/pubmed/35214193 http://dx.doi.org/10.3390/pharmaceutics14020466 |
Ejemplares similares
-
Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations
por: Mandal, Abhirup, et al.
Publicado: (2020) -
Hyaluronic acid conjugates for topical treatment of skin cancer lesions
por: Krishnan, Vinu, et al.
Publicado: (2021) -
Hyaluronic acid–doxorubicin nanoparticles for targeted treatment of colorectal cancer
por: Pan, Daniel C., et al.
Publicado: (2020) -
Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin
por: Pusuluri, Anusha, et al.
Publicado: (2019) -
Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis
por: Gao, Yongsheng, et al.
Publicado: (2021)